FindTrial
Sign In

Developing a model for automated measurement of ICG-R15 in patients with hepatocellular carcinoma

Developing and validation a model for automated measurement of ICG-R15 in patients with hepatocellular carcinoma based on CT images and clinical data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053042
Enrollment
Unknown
Registered
2021-11-10
Start date
2021-11-12
Completion date
Unknown
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative liver failure

Interventions

case series:No

Sponsors

Renji Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. At least 18 years old; 2. Pathological diagnosis of hepatocellular carcinoma; 3. The ICG clearance rate test was performed within 7 days before surgery; 4. Received contrast-enhanced CT scan of upper abdomen before operation.

Exclusion criteria

Exclusion criteria: 1. The quality of CT images is poor; 2. Missing important clinical data.

Design outcomes

Primary

MeasureTime frame
Albumin-bilirubin score ;total bile acid;Prealbumin;Direct bilirubin;Age;gender;collagen proportionate area ;—

Countries

China

Contacts

Public ContactXue Feng

Renji Hospital, Shanghai Jiaotong University School of Medicine

1968232851@qq.com+86 516 6022338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026